Die Suchmaschine für Unternehmensdaten in Europa

EU-Förderung (10,5 Mio. €): H2O Health Outcomes Observatory Hor 01.10.2020 EU-Rahmenprogramm für Forschung und Innovation "Horizont"

Auf einen Blick

Text

H2O Health Outcomes Observatory

Patients' outcomes and experience of health care can be improved through the systematic capture and use of information from their perspective. We are currently not using all the information we could gain from Patients' outcomes and experience of health care can be improved through the systematic capture and use of information from their perspective. We are currently not using all the information we could gain from Patient-Reported Outcomes (PROs) to accurately measure value from the patient perspective. This is due to the lack of standardisation, interoperability and implementation of PRO measurement schemes. We urgently need a European scale network of outcomes data collection, analysis and evidence sharing to inform clinical practice and healthcare decisions. To tackle these issues, this public-private consortium brings together scientists, clinicians and professionals to design and set up independent, patient-centred, Health Outcomes Observatories (H2Os). With input from patients, providers and health care decision makers (health ministries, health insurers, regional health authorities, public health agencies, medicines regulators, health technology assessment agencies), these Observatories will collect data and provide information not only for individual clinical care, but also for evaluation of new technologies and for healthcare decision making. We will establish ethically and legally sound national, or regional, H2Os and run these initially in four countries for three diseases. Based on a hybrid model of federated and centralised data collection, management and analysis, these Observatories will operate under a governance model that will guarantee that data are protected under jurisdictional data protection law. H2Os will be connected to a pan-European umbrella H2O to facilitate interoperability, guide reproducibility in other countries, and promote the benefit of measuring and using patient-centred outcomes at regional, national, European and global levels.


Geförderte Unternehmen:

Firmenname Förderungssumme
Abbvie Inc. 0,00 €
Astrazeneca AB 0,00 €
Breakthrough T1D 0,00 €
Charite - Universitaetsmedizin Berlin 1.126.008 €
Eli Lilly and Company Ltd. 0,00 €
Erasmus Universitair Medisch Centrum Rotterdam 1.279.661 €
F. Hoffmann-LA Roche AG 0,00 €
Forum des Patients Europeens 450.413 €
Fundacio Hospital Universitari Vall D'Hebron - Institut de Recerca 0,00 €
Fundacio Privada Institut D'Investigacio Oncologica de Vall-Hebron (Vhio) 0,00 €
H2O PAN European Observatory 54.688 €
Health Outcomes Observatory - Germany (H2O) e. V. 65.188 €
Health Outcomes Observatory Nederland (H2O-NL) 4.687,50 €
Institut Catala de La Salut 1.068.039 €
Katholieke Universiteit Leuven 458.188 €
King's College London 655.000 €
Medizinische Universitaet Wien 2.102.974 €
Medtronic International Trading Sàrl 0,00 €
Novartis Pharma AG 0,00 €
Pfizer Ltd. 0,00 €
Region Stockholm 548.375 €
Sanofi-Aventis Recherche & Developpement 0,00 €
Stichting Integraal Kankercentrum Nederland 563.813 €
Takeda Pharmaceuticals International AG 0,00 €
Teamit Research SL 665.719 €
THE European Institute for Innovation Through Health Data 564.625 €
THE Hyve B.V. 536.250 €
Trial Nation 0,00 €
Universita Vita-Salute SAN Raffaele 333.063 €

Quelle: https://cordis.europa.eu/project/id/945345

Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.